Delivery Order SPE2DB20D3103-SPE2DB22FP7X3
Award Date 9/7/22
Potential Completion Date 9/8/22
Potential Value $5K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,477.18 Firm Fixed Price Delivery Order covers the supply of Celecoxib 200 mg capsules, a medication used for pain and inflammation management. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
- This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA). The contract is for the delivery of 4,563,043,087 units of the medication Celecoxib 200 mg Capsule, with a total ceiling value of $1,103.10. The contract is a firm fixed-price delivery order with a period of performance through December 11, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,197.61, is for the delivery of 4,562,868,648 capsules of the medication Celecoxib 200 mg. This is a firm fixed-price delivery order contract with an ultimate completion date of November 21, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $361,252.95 delivery order is for the supply of 4,531,831,739 units of the pharmaceutical drug Celecoxib 200mg. The award is for delivery by October 7, 2015 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $374,630.81, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award covers the delivery of Celecoxib 200mg, a pharmaceutical product, under a Firm Fixed Price Delivery Order contract. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at up to $10,857.00, is for the delivery of CELEBREX 200 MG CAPSULE 100S, a prescription medication. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of June 21, 2024. This award is not associated with a set-aside...
- This delivery order, valued at $8,663.41, awards Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) a firm fixed-price contract for Celebrex 200 mg capsules in unit dose packaging (100 count). The contract was awarded on January 8, 2026, with an ultimate completion date of January 9, 2026, and carries no set-aside designation, indicating it was competitively awarded. The Defense Logistics Agency, under its medical supply chain operations, is the funding federal agency, and performance...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Celecoxib 200 mg capsules (500-count units) with a ceiling value of $1,557.18. This firm fixed-price delivery order, which is expected to be completed by August 15, 2025, represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Celecoxib is a nonsteroidal anti-inflammatory drug commonly...
- This federal contract award, with ID SPE2DX15D6028|SPE2DX23FWPGH, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,557.27 firm fixed-price delivery order is for 4560685763 CELECOXIB 200MG 500S, a pharmaceutical product. The award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of pharmaceutical products and medical supplies, including Celebrex 100mg, to support military treatment programs and facilities. The contract is a firm fixed price delivery order valued at $2,650.19 with a performance period through April 9, 2024. Amerisourcebergen Drug Corp also holds an...